A carregar...
Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
BACKGROUND: The combination of umeclidinium (UMEC), a long-acting muscarinic receptor antagonist, and vilanterol (VI), a selective long-acting β(2) agonist, is in development for the treatment of chronic obstructive pulmonary disease (COPD). This study evaluated the pharmacokinetics, safety and tole...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3615930/ https://ncbi.nlm.nih.gov/pubmed/23569370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S40859 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|